I had a different handle on Ariad which I retired years ago but I can appreciate your skepticism. I prefer to keep that old pseudonym retired at this point for a few reasons. In any event, my only agenda on this board is to encourage the longs that have been here for years (and the new ones) not to get discouraged if the buyout takes a bit longer than we'd like. If it was another false alarm the company will continue to do well on its own and the sp will grow organically. I think a buyout is in the works as that was always the intent when Glickman turned over the leadership for that purpose. I think Pfizer has to be considered a frontrunner as there are so many ties to that company but I hope we will benefit from having a number of interested parties.
Market Data 
Markets 
AI
